Original Article
1. Evaluation of glucose-6-phosphate dehydrogenase serum level in patients with multiple sclerosis and neuromyelitis optica

Niloofar Chitsaz; Leila Dehghani; Amir Safi; Nazgol Esmalian-Afyouni; Vahid Shaygannejad; Majid Rezvani; Karim Sohrabi; Kaykhosro Moridi; Milad Moayednia

Volume 18, Issue 4 , Autumn 2019, Pages 150-153

Abstract
  Background: Multiple sclerosis (MS) and neuromyelitis optica (NMO) are both demyelinating disorders and oxidative stress is suggested to have a role in their pathogenesis. Glucose-6-phosphate dehydrogenase (G6PD) produces nicotinamide adenine dinucleotide phosphate (NADPH) via the pentose phosphate pathway. ...  Read More

Original Article
2. Effectiveness and side effects of dimethyl fumarate in multiple sclerosis after 12 months of follow up: An Iranian clinical trial

Mohsen Foroughipour; Sahar Gazeran

Volume 18, Issue 4 , Autumn 2019, Pages 154-158

Abstract
  Background: Multiple sclerosis (MS) is a neurologic disorder with a considerable global burden. During the last decades, some pharmaceutical treatments have been approved for patients with MS. Dimethyl fumarate (DMF) is one of these drugs which has been reported to have early promising results in recent ...  Read More

Review Article
3. Fitness to drive in seizure and epilepsy: A protocol for Iranian clinicians

Nasim Tabrizi

Volume 18, Issue 4 , Autumn 2019, Pages 159-171

Abstract
  Driving restriction is a well-known undesirable consequence of epilepsy and causes significant problems regarding independence and employment for epileptic patients. Many countries all over the world have provided comprehensive protocols in this regard with the aim of providing the possibility of less ...  Read More

Short Communication
4. Thrombolytic treatment in stroke mimic, inevitable but fortunately safe: An observational study from Iran

Sara Esmaeili; Motahareh Afrakhteh; Maryam Bahadori; Seyedeh Fahimeh Shojaei; Rezan Ashayeri; Masoud Mehrpour

Volume 18, Issue 4 , Autumn 2019, Pages 172-175

Abstract
  Background: A number of patients with symptoms of acute cerebral ischemia may have other causes called stroke mimics (SM). The prevalence of SM can be as high as 31% in some reports, and these patients are potentially at the risk of intravenous thrombolysis (IVT) therapy and its complications. This study ...  Read More

Letter to the Editor
5. A survey from Turkey and Iran on comparison of risk factors and etiology in ischemic stroke

Gulcin Benbir Senel; Ayse Deniz Elmali; Kaveh Mehrvar; Mehdi Farhoudi; Mohammad Aboutalebi; Mahsa Rezaei; Birsen Ince

Volume 18, Issue 4 , Autumn 2019, Pages 176-178

Abstract
  Background: Multiple sclerosis (MS) is a neurologic disorder with a considerable global burden. During the last decades, some pharmaceutical treatments have been approved for patients with MS. Dimethyl fumarate (DMF) is one of these drugs which has been reported to have early promising results in recent ...  Read More